New horizons in the treatment of multiple sclerosis.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 8487695.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
OBJECTIVE: To review and discuss novel therapeutic approaches to multiple sclerosis (MS), particularly strategies designed to modulate immunopathogenetic mechanisms. DATA SOURCES: Recent medical and scientific publications and the proceedings of recent conferences in Australia and the United States. CONCLUSIONS: Clearer understanding of the pathogenetic mechanisms leading to inflammation and demyelination in MS is suggesting new strategies for intervention. Both antigen-specific and non-antigen-specific immunomodulation can be achieved in animal models, and human clinical trials of several new agents can be expected shortly.